Faqja 1 nga 687 rezultatet
The invention relates to an analgesic and inflammation-inhibiting medicament.
In the therapy of inflammatory rheumatological diseases, in particular rheumatoid arthritis, two different medicinal principles are used side by side. The first consists in the reduction of the pain and the inflammatory
TECHNICAL FIELD
This invention relates to novel compound 14-O-p-chlorobenzoylaconine or a salt thereof, as well as to a novel analgesic/anti-inflammatory agent containing the 14-O-p-chlorobenzoylaconine or salt thereof as active ingredient.
BACKGROUND ART
Aconitine alkaloids contained in the
BACKGROUND OF THE INVENTION
.DELTA..sup.1 -Tetrahydrocannabinol (THC) (Formula I) is the major psychoactive constituent of marijuana (Hollister, L.E. Science, 172:21-29, 1971; Isbell, H., Gorodetsky, C. W., Jasinski, D., Claussen, V., von Spulak, F. and Korte, F. Psychopharmacologia, 11:184-188,
TECHNICAL FIELD
The present invention relates to an external preparation having an anti-inflammatory analgesic effect.
BACKGROUND ART
Conventionally, a Non-Steroidal Anti-Inflammatory Drug (hereinafter, referred to as "NSAID") is known as an anti-inflammatory analgesic. This NSAID has an action of
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to novel pharmaceutical compositions of matter comprising one or more non-steroidal anti-inflammatory drugs in combination with at least one skeletal muscle relaxant, and to methods of using said
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to novel pharmaceutical compositions of matter comprising one or more non-steroidal anti-inflammatory drugs in combination with at least one skeletal muscle relaxant, and to methods of using said
BACKGROUND OF THE INVENTION
Manoalide, from the marine sponge Luffariella variabilis (POLEJAEFF) has been reported by E. D. de Silva and P. J. Scheuer; Tetrahedron Letters Vol. 21, pp 1611-1614 Pergamon Press Ltd. 1980. The structure of this compound is as follows: ##STR1##
Seco-manoalide is
The present invention relates to nicotinoyl ester of (3-4)-O-isopropylidene pyridoxine and the hydrochloride thereof having the formula: ##STR2## which is endowed with interesting pharmacological properties by which it is useful for particular therapeutical uses. The compound of the invention is in
BACKGROUND OF THE INVENTION
The present invention relates generally to novel pharmaceutical compositions of matter comprising diphenhydramine and one or more non-steroidal anti-inflammatory drugs (NSAID) having analgesic and anti-inflammatory properties, and to methods of using said compositions to
BACKGROUND OF THE INVENTION
The present invention relates generally to novel pharmaceutical compositions of matter comprising diphenhydramine and one or more non-steroidal anti-inflammatory drugs (NSAID) having analgesic and anti-inflammatory properties, and to methods of using said compositions to
BACKGROUND OF THE INVENTION
The present invention relates generally to novel pharmaceutical compositions of matter comprising diphenhydramine and one or more non-steroidal anti-inflammatory drugs (NSAID) having analgesic and anti-inflammatory properties, and to methods of using said compositions to
BACKGROUND OF THE INVENTION
The present invention relates generally to novel pharmaceutical compositions of matter comprising diphenhydramine and one or more non-steroidal anti-inflammatory drugs (NSAID) having analgesic and anti-inflammatory properties, and to methods of using said compositions to
BACKGROUND OF THE INVENTION
The present invention relates generally to novel pharmaceutical compositions of matter comprising diphenydramine and one or more non-steroidal anti-inflammatory drugs (NSAID) having analgesic and anti-inflammatory properties, and to methods of using said compositions to
BACKGROUND OF THE INVENTION
The present invention relates generally to novel pharmaceutical compositions of matter comprising diphenhydramine and one or more non-steroidal anti-inflammatory drugs (NSAID) having analgesic and anti-inflammatory properties, and to methods of using said compositions to
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to an anti-inflammatory analgesic cataplasm comprising indomethacin as the active ingredient, and to a process for the production of such cataplasm.
2. Description of the Prior Art
Indomethacin is a compound represented by